| |
|
|
|
AzurRx BioPharma- Inc.  
|
|
2.5 0.1 (0.04%) |
08-14 16:00 |
|
Open: |
2.41 |
Pre close: |
2.4 |
Target:
|
3.28 
|
|
High: |
2.5 |
Low: |
2.34 |
Resistance:
|
2.81
3.18
|
|
Volume: |
27,005 |
Market Cap: |
42M |
Support:
|
2.20
1.83
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.35
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
2.41 |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
2.85 |
Stochastic Oscillator |
%K(14,3):
|
34.01 |
|
MA(250): |
3.15 |
%D(3): |
29.15 |
|
Average Volume(K) |
3-Month: |
6215
|
52-Week |
High:
|
5.25 |
|
10-Days: |
4112 |
Low: |
2.20 |
|
RSI |
RSI(14):
|
42.57 |
Change(%): |
-36.4 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.570 |
Return on Equity (ttm) |
-927.8 |
Shares Out. (M) |
16.79 |
|
EPS Est. Current Year |
-0.850 |
Return on Assets (ttm) |
-223.4 |
Shares Float (M) |
16.25 |
|
EPS Est. Next Year |
-0.670 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.30 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
24.50 |
|
Forward EPS |
-0.640 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
54 |
|
Book Value (p.s.) |
35.310 |
EBITDA (p.s.) |
-0.282 |
P/E |
-4.19 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.07 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.23 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.64 |
P/CF |
-4.88 |
|
|
|
|
|
|
